• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮受体——代谢综合征的新角色?

The mineralocorticoid receptor-an emerging player in metabolic syndrome?

机构信息

Endocrine Hypertension Research Centre, The University of Queensland Diamantina Institute & Princess Alexandra Hospital, Brisbane, QLD, 4102, Australia.

Department of Endocrinology & Diabetes, Princess Alexandra Hospital, Brisbane, QLD, 4102, Australia.

出版信息

J Hum Hypertens. 2021 Feb;35(2):117-123. doi: 10.1038/s41371-020-00467-3. Epub 2021 Feb 1.

DOI:10.1038/s41371-020-00467-3
PMID:33526798
Abstract

Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular diseases, and comprises obesity, hypertension, impaired glucose metabolism and dyslipidaemia. It is well recognised that the mineralocorticoid receptor (MR) plays an important role in blood pressure regulation via its effect on salt and water retention in renal tubules, with hypertension being a key feature in primary aldosteronism patients with excess adrenal production of aldosterone, the primary ligand for MRs in the epithelial tissues. MRs are also expressed in a number of non-epithelial tissues including adipose tissue; in these tissues, glucocorticoids or cortisol can also activate MRs due to low levels of 11-beta-hydroxysteroid-dehydrogenase type 2 (11-βHSD2), the enzyme which inactivates cortisol. There is increasing evidence suggesting that over-activation of MRs plays a role in the pathophysiology of the other components of metabolic syndrome, promoting adiposity, inflammation and glucose intolerance, and that MR antagonists may confer beneficial effects on energy and substrate homeostasis and cardiometabolic diseases. This review discusses the advances in the literature shedding light on the MR as an emerging player in metabolic syndrome.

摘要

代谢综合征是一组会增加心血管疾病风险的病症,包括肥胖、高血压、葡萄糖代谢受损和血脂异常。众所周知,醛固酮受体(MR)通过影响肾脏小管中盐和水的保留来在血压调节中发挥重要作用,而高血压是原发性醛固酮增多症患者的一个关键特征,原发性醛固酮增多症患者的肾上腺会过量产生 MR 的主要配体醛固酮。MR 也在许多非上皮组织中表达,包括脂肪组织;在这些组织中,由于 11-β 羟类固醇脱氢酶 2(11-βHSD2)水平较低,糖皮质激素或皮质醇也可以激活 MR,11-βHSD2 是使皮质醇失活的酶。越来越多的证据表明,MR 的过度激活在代谢综合征其他成分的病理生理学中发挥作用,促进肥胖、炎症和葡萄糖不耐受,而 MR 拮抗剂可能对能量和底物稳态以及心脏代谢疾病有益。这篇综述讨论了文献中的进展,这些进展阐明了 MR 作为代谢综合征中一个新出现的参与者的作用。

相似文献

1
The mineralocorticoid receptor-an emerging player in metabolic syndrome?醛固酮受体——代谢综合征的新角色?
J Hum Hypertens. 2021 Feb;35(2):117-123. doi: 10.1038/s41371-020-00467-3. Epub 2021 Feb 1.
2
Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.醛固酮:在心肾代谢综合征和耐药性高血压中的作用。
Prog Cardiovasc Dis. 2010 Mar-Apr;52(5):401-9. doi: 10.1016/j.pcad.2009.12.004.
3
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.醛固酮、盐皮质激素受体与代谢综合征:盐皮质激素受体拮抗剂的作用。
Curr Vasc Pharmacol. 2012 Mar;10(2):238-46. doi: 10.2174/157016112799304969.
4
Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology.醛固酮与盐皮质激素受体——生理学与病理生理学
Int J Mol Sci. 2017 May 11;18(5):1032. doi: 10.3390/ijms18051032.
5
Mineralocorticoid receptor signalling in primary aldosteronism.原发性醛固酮增多症中的盐皮质激素受体信号转导。
J Endocrinol. 2023 Aug 28;259(1). doi: 10.1530/JOE-22-0249. Print 2023 Sep 1.
6
Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome.醛固酮受体、盐敏感性高血压和代谢综合征。
Hypertension. 2010 Apr;55(4):813-8. doi: 10.1161/HYPERTENSIONAHA.109.149062. Epub 2010 Feb 22.
7
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.醛固酮受体在阻塞性睡眠呼吸暂停和代谢综合征中的作用。
Curr Hypertens Rep. 2018 Mar 19;20(3):23. doi: 10.1007/s11906-018-0819-5.
8
Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.醛固酮过量与盐皮质激素受体拮抗的血管后果
Curr Hypertens Rev. 2017;13(1):46-56. doi: 10.2174/1573402113666170228151402.
9
The ubiquitous mineralocorticoid receptor: clinical implications.无处不在的盐皮质激素受体:临床意义。
Curr Hypertens Rep. 2012 Dec;14(6):573-80. doi: 10.1007/s11906-012-0297-0.
10
Syndromes that Mimic an Excess of Mineralocorticoids.酷似盐皮质激素过多的综合征
High Blood Press Cardiovasc Prev. 2016 Sep;23(3):231-5. doi: 10.1007/s40292-016-0160-5. Epub 2016 Jun 1.

引用本文的文献

1
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.糖尿病肾病的发病机制、生物标志物及治疗方法:当前见解与未来展望
J Clin Med. 2025 Jan 23;14(3):727. doi: 10.3390/jcm14030727.
2
Mineralocorticoid receptor blockage in kidney transplantation: too much of a good thing or not?肾移植中盐皮质激素受体阻断:是好事过头还是并非如此?
Int Urol Nephrol. 2025 Mar;57(3):839-854. doi: 10.1007/s11255-024-04256-6. Epub 2024 Oct 29.
3
The prevalence of metabolic syndrome in primary aldosteronism and essential hypertension: A systematic review and meta-analysis.

本文引用的文献

1
Body mass index predicts aldosterone production in hypertensive postmenopausal women.体重指数可预测高血压绝经后女性的醛固酮生成。
Clin Exp Hypertens. 2020;42(3):281-286. doi: 10.1080/10641963.2019.1649683. Epub 2019 Jul 30.
2
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial).螺内酯对 2 型糖尿病患者肝脏脂肪和代谢的影响:一项随机、双盲、安慰剂对照试验(MIRAD 试验)。
Diabetes Obes Metab. 2019 Oct;21(10):2305-2314. doi: 10.1111/dom.13809. Epub 2019 Jul 5.
3
Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism.
原发性醛固酮增多症和原发性高血压中代谢综合征的患病率:系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2024 Aug;26(8):879-889. doi: 10.1111/jch.14873. Epub 2024 Jul 22.
4
Metabolic outcomes in obese mice undergoing one-anastomosis gastric bypass (OAGB) with a long or a short biliopancreatic limb.接受长或短胆胰支的单吻合口胃旁路术(OAGB)的肥胖小鼠的代谢结果
Am J Physiol Endocrinol Metab. 2024 Jun 1;326(6):E819-E831. doi: 10.1152/ajpendo.00327.2023. Epub 2024 Apr 17.
5
Editorial: Adrenal neuroendocrine system and cardiometabolic health: pathophysiology and clinical implications.社论:肾上腺神经内分泌系统与心脏代谢健康:病理生理学及临床意义
Front Endocrinol (Lausanne). 2023 Oct 27;14:1295655. doi: 10.3389/fendo.2023.1295655. eCollection 2023.
6
Pathogenesis of Hypertension in Metabolic Syndrome: The Role of Fructose and Salt.代谢综合征中高血压的发病机制:果糖和盐的作用。
Int J Mol Sci. 2023 Feb 21;24(5):4294. doi: 10.3390/ijms24054294.
7
The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion.康欣综合征的实体:原发性醛固酮增多症伴自主性皮质醇分泌。
Diagnostics (Basel). 2022 Nov 13;12(11):2772. doi: 10.3390/diagnostics12112772.
8
Antioxidant and antiradical activities depend on adrenal tumor type.抗氧化和抗自由基活性取决于肾上腺肿瘤类型。
Front Endocrinol (Lausanne). 2022 Sep 30;13:1011043. doi: 10.3389/fendo.2022.1011043. eCollection 2022.
9
Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model.小剂量螺内酯可改善来曲唑诱导的多囊卵巢综合征大鼠模型脂肪组织炎症和细胞凋亡。
BMC Endocr Disord. 2022 Sep 7;22(1):224. doi: 10.1186/s12902-022-01143-y.
10
Considerations for the future: current and future treatment paradigms with mineralocorticoid receptor antagonists-unmet needs and underserved patient cohorts.未来展望:盐皮质激素受体拮抗剂的当前及未来治疗模式——未满足的需求与服务不足的患者群体
Kidney Int Suppl (2011). 2022 Apr;12(1):69-75. doi: 10.1016/j.kisu.2021.11.008. Epub 2022 Mar 18.
原发性醛固酮增多症患者内脏脂肪与血浆醛固酮浓度之间的关系
J Endocr Soc. 2018 Sep 17;2(11):1236-1245. doi: 10.1210/js.2018-00187. eCollection 2018 Nov 1.
4
Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA.肾素-血管紧张素-醛固酮系统、糖代谢与 2 型糖尿病发病风险:MESA 研究。
J Am Heart Assoc. 2018 Sep 4;7(17):e009890. doi: 10.1161/JAHA.118.009890.
5
Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation.在代谢失调的HIV感染者中醛固酮与肝脏脂肪的显著关联。
J Endocr Soc. 2018 Sep 3;2(10):1147-1157. doi: 10.1210/js.2018-00194. eCollection 2018 Oct 1.
6
Mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo-controlled cross-over study.醛固酮拮抗剂增强人体棕色脂肪组织功能:一项随机安慰剂对照交叉研究。
Diabetes Obes Metab. 2019 Mar;21(3):509-516. doi: 10.1111/dom.13539. Epub 2018 Oct 14.
7
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.肥胖是特发性醛固酮增多症的关键致病因素。
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866.
8
The Global Epidemic of the Metabolic Syndrome.代谢综合征的全球流行。
Curr Hypertens Rep. 2018 Feb 26;20(2):12. doi: 10.1007/s11906-018-0812-z.
9
The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease.瘦素对醛固酮分泌的调节:在肥胖相关心血管疾病中的意义。
Curr Opin Nephrol Hypertens. 2018 Mar;27(2):63-69. doi: 10.1097/MNH.0000000000000384.
10
Sex Differences in Mechanisms of Hypertension Associated With Obesity.与肥胖相关的高血压机制中的性别差异。
Hypertension. 2018 Jan;71(1):15-21. doi: 10.1161/HYPERTENSIONAHA.117.09980. Epub 2017 Nov 13.